LABCORP HOLDINGS INC. Deferred Revenue (Non-Current)
LABCORP HOLDINGS INC. (LH) had Deferred Revenue (Non-Current) of $2.50 million as of 2015-12-31, per its 10-K filed 2016-03-01.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredRevenueNoncurrent · last filed 2016-03-01
- 2015-12-31: Deferred Revenue, Noncurrent $2.50M.
- 2014-12-31: Deferred Revenue, Noncurrent $3.40M.
- 2013-12-31: Deferred Revenue, Noncurrent $4.00M.
- 2012-12-31: Deferred Revenue, Noncurrent $5.40M.
| Period end | Deferred Revenue, Noncurrent |
|---|---|
| 2015-12-31 | $2.50M 10-K · filed 2016-03-01 |
| 2014-12-31 | $3.40M 10-K · filed 2016-03-01 |
| 2013-12-31 | $4.00M 10-K · filed 2015-02-26 |
| 2012-12-31 | $5.40M 10-K · filed 2014-02-25 |
| 2011-12-31 | $5.90M 10-K · filed 2013-02-26 |
| 2010-12-31 | $7.20M 10-K · filed 2012-02-24 |
| 2009-12-31 | $22.50M 10-K/A · filed 2011-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |